샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777453

세계의 집단검진 시장

Population Screening
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 467 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

집단검진 세계 시장은 2030년까지 353억 달러에 달할 전망

2024년에 272억 달러로 추정되는 집단검진 세계 시장은 2024-2030년 분석 기간 동안 CAGR 4.5%로 성장하여 2030년에는 353억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 국가별 검진은 CAGR 5.1%를 기록하며 분석 기간 종료까지 257억 달러에 달할 것으로 예상됩니다. 주별 검진 분야의 성장률은 분석 기간 동안 CAGR 2.9%로 추정됩니다.

미국 시장은 74억 달러로 추정, 중국은 CAGR 8.2%로 성장 예측

미국의 집단검진 시장은 2024년에 74억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 73억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 8.2%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.8%와 3.5%로 예측됩니다. 유럽에서는 독일이 CAGR 2.6%로 성장할 것으로 예측됩니다.

집단검진 시장 - 주요 동향과 촉진요인 정리

집단검진이란 무엇이며, 왜 공중 보건에 중요한가?

집단검진은 무증상 개인의 질병, 유전적 상태, 위험 요인을 조기에 발견하기 위해 고안된 공중보건의 사전 예방적 접근법입니다. 증상이 있는 개인의 상태를 확인하는 진단 검사와 달리, 집단검진는 증상이 나타나기 전에 건강 문제를 발견하여 조기 개입, 치료 결과 개선, 의료 비용 절감을 가능하게 하는 것을 목표로 합니다. 일반적인 예로는 암 검진(유방촬영술, 대장내시경, HPV 검사), 대사 이상 및 유전자 이상 신생아 검진, 심혈관 위험 검진, 감염병 검진(HIV, 간염, 결핵 검사) 등이 있습니다.

세계 각국의 정부와 의료 기관은 질병 부담과 사망률을 줄이기 위해 검진 프로그램을 시행하고 있습니다. 집단검진 프로그램은 역사적으로 자궁경부암 감소, 지질 프로파일링을 통한 심혈관 건강 개선, 유전성 질환 예방을 위한 유전적 보인자 검진을 통해 자궁경부암을 예방하는 데 효과적이었습니다. 만성질환 및 노화 관련 질환의 유병률이 증가함에 따라 의료 시스템은 더 많은 질병을 다루고, 새로운 기술을 통합하고, 인구통계학적, 유전적, 생활습관적 요인에 따라 위험 평가를 개별화하기 위해 집단검진 노력을 확대하고 있습니다.

기술이 집단검진 방법을 어떻게 변화시키고 있는가?

의료 기술, 인공지능(AI), 빅데이터 분석의 발전으로 집단검진 프로그램의 정확성, 효율성, 확장성이 크게 향상되고 있습니다. 가장 획기적인 발전 중 하나는 방사선과 병리학에서 AI를 활용한 영상 진단과 기계 학습 알고리즘을 사용하는 것입니다. AI는 유방촬영, 폐 스캔, 망막 영상을 기존 방법보다 높은 정확도로 분석할 수 있어 위양성을 줄이고 암, 당뇨망막병증, 신경퇴행성 질환을 조기에 발견할 수 있습니다.

또 다른 큰 도약은 액체 생검과 다중 암 조기발견(MCED) 검사의 등장입니다. 혈액 샘플을 이용해 조기 암을 나타내는 순환 종양 DNA(ctDNA) 및 기타 바이오마커를 검출합니다. 이러한 비침습적 검사는 기존의 조직 생검을 대체할 수 있는 보다 안전하고 간편한 검사로 대규모 검진 프로그램에 이상적입니다. 또한, 유전체학 및 전장유전체 염기서열분석(WGS)의 발전으로 유전성 질환, 약리유전체 반응, 알츠하이머병 및 당뇨병과 같은 복잡한 질병에 대한 소인을 선별할 수 있게 되었습니다.

웨어러블 헬스 기술과 디지털 바이오마커의 통합도 검진 방법을 재구성하고 있습니다. 스마트워치, 지속혈당측정기, ECG 탑재 웨어러블 등의 장치는 지속적인 건강 모니터링, 실시간 데이터 수집, 부정맥, 고혈압, 대사 이상을 조기에 발견할 수 있도록 합니다. 이러한 기술 혁신은 일회성 선별 검사에서 지속적인 건강 모니터링으로 전환할 수 있으며, 의료진이 비정상적인 생리적 변화의 징후를 조기에 감지하고 개입할 수 있도록 돕습니다.

집단검진 확대를 형성하는 주요 동향은 무엇인가?

집단검진의 가장 중요한 트렌드 중 하나는 개인화된 위험 기반 선별검사 프로토콜로 전환하는 것입니다. 기존에는 검진 가이드라인이 연령이나 광범위한 집단의 기준을 기준으로 삼았다면, 정밀의료와 위험도 계층화라는 새로운 연구로 인해 개인별 맞춤 검진 권고가 이루어지고 있습니다. 예를 들어, 40세부터 보편적인 유방암 검진 대신 유전적 위험도 평가와 가족력 분석을 통해 개인이 더 일찍 검진을 시작해야 하는지, 더 자주 검진을 받아야 하는지를 결정하는 데 도움을 주고 있습니다. 이 접근법을 통해 불필요한 검사를 최소화하면서 고위험군 환자의 결과를 개선할 수 있습니다.

재택 검진 및 자가 검진 확대도 의료 서비스 접근성의 변화를 촉진하고 있습니다. COVID-19 사태로 인해 재택진단 검사, 원격의료 상담, 우편 검체 채취 키트 도입이 가속화되었고, 이후 HPV, 대장암, 감염성 질환 검진으로 확대되었습니다. 이러한 분산형 모델은 특히 농촌 지역이나 의료 시설에 대한 접근성이 제한적인 사람들에게 더 높은 참여율, 의료 격차 해소, 편의성 향상을 가능하게 합니다.

또 다른 성장 추세는 직장 건강 증진 프로그램이나 민관 파트너십에 집단검진을 통합하는 것입니다. 대기업과 보험사들은 질병의 조기 발견이 장기적으로 의료비를 절감하고 근로자의 생산성을 향상시킨다는 사실을 인식하고, 직원 복지의 일환으로 예방 검진을 제공하고 있습니다. 마찬가지로, 공중 보건 기관은 민간 생명공학 기업들과 협력하여 대규모로 배포할 수 있는 비용 효율적인 AI 기반 검진 솔루션을 개발하고 있습니다. 이러한 파트너십은 검진 이니셔티브에 대한 접근성을 확대하고 공중보건 성과를 최적화하는 데 도움이 되고 있습니다.

집단검진 시장의 성장을 촉진하는 요인은 무엇인가?

집단검진 시장의 성장은 기술 발전, 정부 자금 증가, 질병 보장 범위 확대, 비감염성 질환(NCDs)의 유병률 증가 등 여러 요인에 의해 이루어집니다. 암, 심혈관질환, 당뇨병과 같은 만성질환의 세계적 부담 증가는 조기 발견을 통한 적극적인 질병 관리의 필요성을 높이고 있으며, 정부와 의료 기관은 검진에 우선순위를 두고 예방 의료에 더 많은 예산을 배정하도록 촉구하고 있습니다.

또 다른 주요 원동력은 유전자 시퀀싱 및 바이오마커 분석 비용이 낮아지고 고급 검진 기술이 더 저렴하고 쉽게 이용할 수 있게 되었다는 점입니다. 차세대 염기서열분석(NGS)과 AI를 활용한 진단은 현재 일상적인 검진 프로그램에 통합되어 유전적 소인, 암 돌연변이, 자가면역 마커를 조기에 식별할 수 있게 해줍니다. 이 때문에 특히 미국, 유럽, 일본 등 신흥 헬스케어 시장에서는 유전자 검진 및 정밀 검사 기술의 채택률이 높아지고 있습니다.

규제와 정책 개혁도 조직적 검진 프로그램 확대에 박차를 가하고 있습니다. 세계 각국 정부는 암 검진 보험 적용, 신생아 검진 확대, 감염병 검사 의무화 등을 시행하고 있으며, 조기발견 서비스의 혜택을 받는 인구의 비율이 꾸준히 증가하고 있습니다. 또한, 클라우드 컴퓨팅과 AI 기반 데이터 분석의 발전으로 전자 의료 기록(EHR)의 통합이 개선되어 환자의 검진 기록, 위험 요인, 후속 개입을 더 잘 추적할 수 있게 되었습니다.

또한, 소비자 주도형 헬스케어와 디지털 헬스 플랫폼의 역할은 개인의 건강검진 프로그램 참여 방식을 재구성하고 있습니다. 소비자 직접 의뢰(DTC) 건강검진 업체의 등장은 의사의 소개 없이도 집에서 검진 키트나 유전적 위험도 평가를 구매할 수 있게함으로써 개인이 자신의 건강을 관리할 수 있는 권한을 부여하고 있습니다. 예방적 건강관리와 장수에 초점을 맞춘 진단에 대한 소비자의 인식이 높아짐에 따라, 편리하고 기술 기반의 검진 솔루션에 대한 수요는 전 세계적으로 가속화될 것으로 예상됩니다.

부문

지역 유형(국가별 검진, 주별 검진), 제품 유형(하드웨어 기기, 검사/실험실 서비스, 분석/해석), 검진 유형(대량 검진, 프리미엄 검진), 사업 유형(병원, 조사기관, 진단 실험실)

조사 대상 기업 사례

  • Abbott Laboratories
  • Aduro
  • Agilent Technologies
  • ARUP Laboratories
  • CHC Wellbeing
  • eHealthScreenings
  • Empower Health Services
  • F. Hoffmann-La Roche Ltd.
  • Gene by Gene, Ltd.
  • Health Advocate
  • Health Designs
  • Illumina, Inc.
  • LGC Limited
  • Novogene Corporation
  • Onsite Health Diagnostics
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • US Wellness

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴로 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.05

Global Population Screening Market to Reach US$35.3 Billion by 2030

The global market for Population Screening estimated at US$27.2 Billion in the year 2024, is expected to reach US$35.3 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. National Screening, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$25.7 Billion by the end of the analysis period. Growth in the State-wise Screening segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.4 Billion While China is Forecast to Grow at 8.2% CAGR

The Population Screening market in the U.S. is estimated at US$7.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.3 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Population Screening Market - Key Trends & Drivers Summarized

What Is Population Screening and Why Is It Crucial for Public Health?

Population screening is a proactive approach in public health designed to identify diseases, genetic conditions, or risk factors in asymptomatic individuals at an early stage. Unlike diagnostic tests, which confirm a condition in individuals with symptoms, population screening aims to detect health concerns before symptoms develop, allowing for early intervention, improved treatment outcomes, and reduced healthcare costs. Common examples include cancer screening (mammograms, colonoscopies, and HPV tests), newborn screening for metabolic and genetic disorders, cardiovascular risk screening, and infectious disease screening (HIV, hepatitis, and tuberculosis tests).

Governments and healthcare organizations worldwide implement screening programs to reduce disease burden and mortality rates. Mass screening programs have historically been effective in reducing cervical cancer through Pap smears, improving cardiovascular health through lipid profiling, and preventing hereditary conditions through genetic carrier screening. With the increasing prevalence of chronic diseases and age-related conditions, healthcare systems are expanding population screening efforts to cover more conditions, integrate new technologies, and personalize risk assessment based on demographic, genetic, and lifestyle factors.

How Is Technology Revolutionizing Population Screening Methods?

Advancements in medical technology, artificial intelligence (AI), and big data analytics are significantly improving the accuracy, efficiency, and scalability of population screening programs. One of the most transformative developments is the use of AI-powered imaging and machine learning algorithms in radiology and pathology. AI can analyze mammograms, lung scans, and retinal images with higher accuracy than traditional methods, reducing false positives and enabling earlier detection of cancer, diabetic retinopathy, and neurodegenerative diseases.

Another major breakthrough is the rise of liquid biopsy and multi-cancer early detection (MCED) tests, which use blood samples to detect circulating tumor DNA (ctDNA) and other biomarkers indicative of early-stage cancers. These non-invasive tests offer a safer and more convenient alternative to traditional tissue biopsies, making them ideal for large-scale screening programs. Additionally, advancements in genomics and whole-genome sequencing (WGS) have made it possible to screen individuals for inherited diseases, pharmacogenomic responses, and predisposition to complex conditions like Alzheimer's and diabetes.

The integration of wearable health technology and digital biomarkers is also reshaping how screening is conducted. Devices such as smartwatches, continuous glucose monitors, and ECG-equipped wearables allow for continuous health monitoring, real-time data collection, and early detection of arrhythmias, hypertension, and metabolic disorders. These innovations enable a shift from one-time screening tests to ongoing health surveillance, allowing healthcare providers to intervene at the earliest signs of abnormal physiological changes.

What Are the Key Trends Shaping the Expansion of Population Screening?

One of the most significant trends in population screening is the move toward personalized and risk-based screening protocols. Traditionally, screening guidelines were based on age and broad population criteria, but emerging research in precision medicine and risk stratification is leading to tailored screening recommendations. For example, instead of universal breast cancer screening starting at age 40, genetic risk assessment and family history analysis now help determine whether an individual should start earlier or undergo more frequent screenings. This approach minimizes unnecessary tests while improving outcomes for high-risk individuals.

The expansion of home-based and self-administered screening tests is also driving a shift in healthcare accessibility. The COVID-19 pandemic accelerated the adoption of at-home diagnostic tests, telemedicine consultations, and mail-in sample collection kits, which have since been expanded to HPV, colorectal cancer, and infectious disease screening. These decentralized models allow for higher participation rates, reduced healthcare disparities, and increased convenience, especially for populations in rural areas or those with limited access to medical facilities.

Another growing trend is the integration of population screening into workplace wellness programs and public-private partnerships. Large corporations and insurance providers are now offering preventive health screenings as part of employee benefits, recognizing that early disease detection reduces long-term medical costs and improves workforce productivity. Similarly, public health agencies are collaborating with private biotech firms to develop cost-effective, AI-powered screening solutions that can be deployed at scale. These partnerships help expand access to screening initiatives and optimize public health outcomes.

What Factors Are Driving the Growth of the Population Screening Market?

The growth in the population screening market is driven by several factors, including technological advancements, increased government funding, expanding disease coverage, and the rising prevalence of non-communicable diseases (NCDs). The increasing global burden of chronic diseases such as cancer, cardiovascular disease, and diabetes has heightened the need for proactive disease management through early detection, prompting governments and healthcare organizations to prioritize screening initiatives and allocate larger budgets for preventive care.

Another key driver is the falling costs of genetic sequencing and biomarker analysis, making advanced screening technologies more affordable and accessible. Next-generation sequencing (NGS) and AI-powered diagnostics are now being integrated into routine screening programs, allowing for early identification of genetic predispositions, cancer mutations, and autoimmune markers. This has led to higher adoption rates of genetic and precision screening techniques, particularly in developed healthcare markets such as the United States, Europe, and Japan.

Regulatory initiatives and policy reforms are also fueling the expansion of organized screening programs. Governments worldwide are implementing mandates for cancer screening coverage, newborn screening expansion, and infectious disease testing, ensuring that a larger percentage of the population benefits from early detection services. Additionally, advances in cloud computing and AI-driven data analytics are improving electronic health records (EHR) integration, allowing for better tracking of patient screening histories, risk factors, and follow-up interventions.

Furthermore, the role of consumer-driven healthcare and digital health platforms is reshaping how individuals participate in screening programs. The rise of direct-to-consumer (DTC) health testing companies has empowered individuals to take control of their health by purchasing at-home screening kits and genetic risk assessments without requiring physician referrals. As consumer awareness about preventive healthcare and longevity-focused diagnostics grows, the demand for convenient, technology-enabled screening solutions is expected to continue accelerating worldwide.

SCOPE OF STUDY:

The report analyzes the Population Screening market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Region Type (National Screening, State-wise Screening); Product Type (Hardware Equipment, Testing / Lab Services, Analytics / Interpretation); Screening Type (Mass Screening, Premium Screening); Business Type (Hospitals, Research Institutes, Diagnostic Labs)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Aduro
  • Agilent Technologies
  • ARUP Laboratories
  • CHC Wellbeing
  • eHealthScreenings
  • Empower Health Services
  • F. Hoffmann-La Roche Ltd.
  • Gene by Gene, Ltd.
  • Health Advocate
  • Health Designs
  • Illumina, Inc.
  • LGC Limited
  • Novogene Corporation
  • Onsite Health Diagnostics
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • US Wellness

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Population Screening - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Healthcare Awareness Drives Adoption of Population Screening Programs
    • Increasing Incidence of Chronic Diseases Accelerates Demand for Screening Solutions
    • Growing Focus on Preventive Healthcare Strengthens the Business Case for Population Screening
    • Advances in Genetic Testing and Biotechnology Propel Growth of Genetic Screening Programs
    • Shift Towards Personalized Medicine Expands Addressable Market Opportunity for Population Screening
    • Regulatory Push for Early Detection of Diseases Sparks Demand for Screening Services
    • Technology Innovations in Screening Tools Enhance Diagnostic Accuracy and Drive Market Growth
    • Integration of Artificial Intelligence and Machine Learning in Screening Platforms Drives Adoption
    • Public Health Initiatives Promote Widespread Adoption of Population Screening Programs
    • Expansion of Healthcare Infrastructure in Emerging Markets Fuels Growth in Screening Demand
    • Growing Aging Population Drives the Need for Regular Screening and Early Disease Detection
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Population Screening Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Population Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Population Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Population Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for National Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for National Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for National Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for State-wise Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for State-wise Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for State-wise Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Diagnostic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hardware Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hardware Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hardware Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Testing / Lab Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Testing / Lab Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Testing / Lab Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Analytics / Interpretation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Analytics / Interpretation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Analytics / Interpretation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Mass Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Mass Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Mass Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Premium Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Premium Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Premium Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • JAPAN
    • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • CHINA
    • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • EUROPE
    • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Population Screening by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Population Screening by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Population Screening by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • FRANCE
    • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • GERMANY
    • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 134: UK Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: UK 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Spain 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Russia 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Europe 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Population Screening by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Asia-Pacific 15-Year Perspective for Population Screening by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Australia 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • INDIA
    • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 209: India Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: India 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: South Korea 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Population Screening by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Population Screening by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Latin America 15-Year Perspective for Population Screening by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Argentina 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Brazil 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Mexico 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Latin America 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Population Screening by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Population Screening by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Middle East 15-Year Perspective for Population Screening by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Iran 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Israel 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Saudi Arabia 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 359: UAE Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: UAE 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: Rest of Middle East 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
  • AFRICA
    • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 383: Africa Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: Africa 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제